379 related articles for article (PubMed ID: 7044961)
21. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
Löwy I; Leclerc C; Chedid L
Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
[TBL] [Abstract][Full Text] [Related]
22. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE
J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582
[TBL] [Abstract][Full Text] [Related]
23. Modulation of natural killer activity by muramyl peptides: relationship with adjuvant and anti-infectious properties.
Le Garrec Y; Morin A
Nat Immun Cell Growth Regul; 1987; 6(2):65-76. PubMed ID: 2439906
[TBL] [Abstract][Full Text] [Related]
24. Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP).
Tanaka A; Emori K
Am J Pathol; 1980 Mar; 98(3):733-48. PubMed ID: 6767407
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis.
Yamamoto K; Granger DL; Brehmer W; Azuma I; Ribi E
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):127-41. PubMed ID: 6797153
[TBL] [Abstract][Full Text] [Related]
26. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
[TBL] [Abstract][Full Text] [Related]
27. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].
Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV
Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137
[TBL] [Abstract][Full Text] [Related]
28. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
Hornung RL; Longo DL; Gowda VL; Kwak LW
Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
[TBL] [Abstract][Full Text] [Related]
29. Requirements for CD4(+) T cell levels in acute Mycobacterium bovis strain bacille Calmette Guerin (BCG)-induced granulomas differ for optimal mycobacterial control versus granuloma formation.
Hogan LH; Heninger E; Elsner RA; Vonderheid HA; Hulseberg P; Co D; Sandor M
Int Immunol; 2007 May; 19(5):627-33. PubMed ID: 17446212
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.
Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y
Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372
[TBL] [Abstract][Full Text] [Related]
31. Antigenicity study of muroctasin.
Yamaguchi F; Hattori H; Wagai N; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
[TBL] [Abstract][Full Text] [Related]
32. New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats.
Kohashi O; Aihara K; Ozawa A; Kotani S; Azuma I
Lab Invest; 1982 Jul; 47(1):27-36. PubMed ID: 7087395
[TBL] [Abstract][Full Text] [Related]
33. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
Audibert F; Chedid L; Lefrancier P; Choay J; Lederer E
Ann Immunol (Paris); 1977; 128C(3):653-61. PubMed ID: 869513
[TBL] [Abstract][Full Text] [Related]
34. [Adjuvant activity and adjuvant arthritis].
Tanaka A
Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
[No Abstract] [Full Text] [Related]
35. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation.
Yamamoto K; Kato K; Kakinuma M; Brehmer W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952
[TBL] [Abstract][Full Text] [Related]
36. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
37. [Epithelioid cell granuloma (author's transl)].
Okabe M; Okuyama H; Morikawa K
Kekkaku; 1980 Oct; 55(10):435-42. PubMed ID: 7014971
[No Abstract] [Full Text] [Related]
38. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
Löwy I; Leclerc C; Bourgeois E; Chedid L
J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
[TBL] [Abstract][Full Text] [Related]
39. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
[TBL] [Abstract][Full Text] [Related]
40. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
Leclerc C; Bourgeois E; Chedid L
Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
